Leukotrienes as modifiers of preclinical atherosclerosis?

In a registry-based nation-wide Swedish cohort of almost 7 million subjects followed for 3.5 years, montelukast use was associated with a borderline significant protective effect on recurrent stroke [ 73 ].

also in 11,409 other papers